PAVmed Inc (PAVMZ)
USD 0.02
(32.0%)
USD 0.02
(32.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.45 Million | 377 Thousand | 500 Thousand | - | - | - |
| Cost of Revenue | 6.42 Million | 3.61 Million | 585 Thousand | 23 Thousand | 14.22 Thousand | 9790.00 |
| Gross Profit | -3.96 Million | -3.23 Million | -85 Thousand | -23 Thousand | -14.22 Thousand | -9790.00 |
| Operating Expenses | 64.82 Million | 87.69 Million | 54.3 Million | 23.35 Million | 14.29 Million | 10.56 Million |
| Selling, General and Administrative Expenses | 48.53 Million | 60.35 Million | 34.46 Million | 12.38 Million | 7.66 Million | 6.31 Million |
| Research and Development Expenses | 14.27 Million | 25.54 Million | 19.84 Million | 10.96 Million | 6.63 Million | 4.25 Million |
| Other Expenses | 2.02 Million | 1.78 Million | - | - | -558.59 Thousand | -903 Thousand |
| Cost and Expenses | 71.24 Million | 91.3 Million | 54.89 Million | 23.35 Million | 14.29 Million | 10.56 Million |
| Operating Income | -68.79 Million | -90.92 Million | -54.39 Million | -23.35 Million | -14.29 Million | -10.56 Million |
| Interest Expense | 589 Thousand | 1.27 Million | - | 53 Thousand | 32.66 Thousand | 2.39 Million |
| Income Tax Expense | - | -1.94 Million | -5.77 Million | -1.55 Million | -1.33 Million | -204.07 Thousand |
| Earnings before Tax | -79.26 Million | -103.23 Million | -56.12 Million | -35.88 Million | -17.26 Million | -18.17 Million |
| Net Income | -64.17 Million | -101.29 Million | -50.34 Million | -34.32 Million | -15.93 Million | -17.96 Million |
| Earnings Per Share Basic | -9.16 | -15.03 | -9.80 | -10.93 | -8.31 | -12.63 |
| Earnings Per Share Diluted | -9.16 | -15.03 | -9.80 | -10.93 | -8.31 | -12.63 |
| Weighted Average Shares Outstanding | 7.23 Million | 5.93 Million | 5.16 Million | 3.16 Million | 2.01 Million | 1.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.23 Million | 5.93 Million | 5.16 Million | 3.16 Million | 2.01 Million | 1.48 Million |
| Gross Margin | -1.62 | -8.59 | -0.17 | - | - | - |
| EBIT Margin | -30.89 | -246.16 | -108.33 | - | - | - |
| Profit Margin | -26.17 | -268.68 | -100.69 | - | - | - |
| EBITDA | -75.74 Million | -99.41 Million | -55.9 Million | -35.81 Million | -16.67 Million | -12.07 Million |
| Earnings Before Tax Margin | -28.06 | -241.19 | -108.79 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 979 Thousand | 1.01 Million | 1.04 Million | 2.45 Million | 791 Thousand | 166 Thousand |
| Cost of Revenue | 1.97 Million | 2.33 Million | 2.33 Million | 9.35 Million | 1.77 Million | 1.68 Million |
| Gross Profit | -992 Thousand | -1.32 Million | -1.28 Million | -6.9 Million | -988 Thousand | -1.51 Million |
| Operating Expenses | 12.69 Million | 12.71 Million | 15.09 Million | 61.89 Million | 14.54 Million | 14.96 Million |
| Selling, General and Administrative Expenses | 11.05 Million | 10.77 Million | 11.5 Million | - | 10.87 Million | 10.99 Million |
| Research and Development Expenses | 1.64 Million | 1.94 Million | 3.59 Million | - | 3.16 Million | 3.46 Million |
| Other Expenses | 105 Million | 372 Million | 5.77 Million | -1.18 Million | 505 Thousand | -340 Thousand |
| Cost and Expenses | 14.66 Million | 15.04 Million | 17.43 Million | 71.24 Million | 16.31 Million | 16.65 Million |
| Operating Income | -13.68 Million | -14.03 Million | -16.38 Million | -68.79 Million | -15.52 Million | -16.48 Million |
| Interest Expense | 11 Thousand | 16 Thousand | 19 Thousand | 589 Thousand | -159 Thousand | 228 Thousand |
| Income Tax Expense | -4 Billion | 4.27 Billion | -3.37 Million | -12.99 Billion | -4 Million | -3.28 Billion |
| Earnings before Tax | -14.91 Million | -18.51 Million | -17.4 Million | -79.26 Million | -21.75 Million | -17.89 Million |
| Net Income | -10.82 Million | -15.21 Million | -14.03 Million | -64.17 Million | -17.74 Million | -14.53 Million |
| Earnings Per Share Basic | -1.18 | -1.75 | -1.71 | - | -2.38 | -2.09 |
| Earnings Per Share Diluted | -1.18 | -1.75 | -1.71 | - | -2.38 | -2.09 |
| Weighted Average Shares Outstanding | 9.15 Million | 8.69 Million | 8.21 Million | 7.23 Million | 7.46 Million | 6.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.15 Million | 8.69 Million | 8.21 Million | 7.23 Million | 7.46 Million | 6.95 Million |
| Gross Margin | -1.01 | -1.31 | -1.23 | -2.81 | -1.25 | -9.15 |
| EBIT Margin | -13.67 | -13.32 | -14.93 | - | -19.63 | -95.87 |
| Profit Margin | -11.06 | -15.06 | -13.38 | -26.17 | -22.44 | -87.57 |
| EBITDA | -13.37 Million | -13.45 Million | -15.65 Million | - | -15.52 Million | -15.91 Million |
| Earnings Before Tax Margin | -13.98 | -13.90 | -15.62 | -28.06 | -19.63 | -99.30 |
LILA
DYN
AGSTRA
JINDCAP
SAMKRG
ICM